Clopidogrel tablet

What is this medicine?

CLOPIDOGREL helps to prevent blood clots. It reduces the chance of having a heart attack or a stroke in people who have already had a heart attack or a stroke. Clopidogrel can also decrease the chance of a heart attack or stroke in certain groups of people at high risk for these events.

Pharmacokinetics and plavix description or metabolism

After repeated 75 mg oral doses of clopidogrel (base), plasma concentrations of the parent compound, which has no plavix and wac and platelet inhibiting effect, are very low and plavix description or are generally below the quantification limit (0.258 µg/L) beyond two hours after substitute for plavix or dosing.

Clopidogrel is a pro-drug activated in the liver by cytochrome P450 enzymes, including CYP2C19. Due to plavix description me opening of the thiophene ring, the chemical structure of the active has three sites that are stereochemically relevant, making a total of eight possible isomers. These are: a stereocentre at C4 (attached to plavix and hypertension me the —SH thiol group), a double bond at C3—C16, and plavix description or the original stereocentre at C7. Only one of the eight structures is an active antiplatelet drug. This has the following configuration: Z configuration at the C3—C16 double bond, the original S configuration at C7, and when will plavix be generic or although the stereocentre at C4 can't be directly determined, as the thiol group is too reactive, work with the active metabolite of the related drug prasugrel suggests that R-configuration of the C4 group is critical for P2Y12 and plavix description or platelet-inhibitory activity.[citation needed]

The active metabolite has an elimination half-life of about eight hours and plavix blood thinner or acts by forming a disulfide bridge with the platelet ADP receptor. Patients with a variant allele of CYP2C19 are 1.5 to plavix description me 3.5 times more likely to plavix stomach bleeding me die or plavix description and have complications than patients with the high-functioning allele.

Following an oral dose of 14C-labeled clopidogrel in humans, approximately 50% was excreted in the urine and cost of plavix at walmart or approximately 46% in the feces in the five days after plavix description or dosing.

Effect of food: Administration of clopidogrel bisulfate with meals did not significantly modify the bioavailability of clopidogrel as assessed by the pharmacokinetics of the main circulating metabolite.

Absorption and plavix 25 mg or distribution: Clopidogrel is rapidly absorbed after plavix description or oral administration of repeated doses of 75 mg clopidogrel (base), with peak plasma levels (approx. 3 mg/L) of the main circulating metabolite occurring approximately one hour after plavix insert or dosing. The pharmacokinetics of the main circulating metabolite are linear (plasma concentrations increased in proportion to plavix description me dose) in the dose range of 50 to plavix canada me 150 mg of clopidogrel. Absorption is at least 50% based on urinary excretion of clopidogrel-related metabolites. Clopidogrel and plavix description or the main circulating metabolite bind reversibly in vitro to plavix and wac me human plasma proteins (98% and plavix description or 94%, respectively). The binding is nonsaturable in vitro up to substitute for plavix me a concentration of 110 ?g/mL.

Metabolism and plavix description or elimination: In vitro and plavix and hypertension or in vivo, clopidogrel undergoes rapid hydrolysis into its carboxylic acid derivative. In plasma and plavix description or urine, the glucuronide of the carboxylic acid derivative is also observed.

In March 2010, the U.S. Food and when will plavix be generic or Drug Administration (FDA) added a boxed warning to plavix description me Plavix alerting that the drug can be less effective in people who cannot metabolize the drug to plavix blood thinner me convert it to plavix description me its active form.
Page: |1 2 3 4 5 6 7 8 9 10 | > >>